On November 8, 2019, the acquisition of Genomic Health, Inc. by Exact Sciences Corporation was consummated pursuant to the terms of the previously announced Agreement and Plan of Merger, dated as of July 28, 2019, by and among Genomic Health, Exact Sciences and Spring Acquisition Corp., a wholly owned subsidiary of Exact Sciences (Merger Sub). Pursuant to the Merger Agreement, Merger Sub merged with and into Genomic Health (the Merger), with Genomic Health continuing as the surviving corporation. As a result of the Merger, Genomic Health became a wholly owned subsidiary of Exact Sciences.

Pursuant to the Merger Agreement, at the Effective Time, the members of the board of directors of Genomic Health immediately prior to the Effective Time, being Kimberly J. Popovits, Julian C. Baker, Felix J. Baker, Ph.D., Fred E. Cohen, M.D., D.Phil., Barry P. Flannelly, Pharm.D., Henry J. Fuchs, M.D., Ginger L. Graham and Geoffrey M. Parker, resigned from the board of directors of Genomic Health. Also at the Effective Time, the members of the board of directors of Merger Sub immediately prior to the Effective Time, being Kevin T. Conroy, D. Scott Coward and Jeffrey T. Elliott, became members of the board of directors of Genomic Health. As of immediately following the Effective Time, each executive officer of Genomic Health was removed from his or her officership position with Genomic Health.

As of immediately following the Effective Time, each executive officer of Genomic Health was removed from his or her officership position with Genomic Health. As of immediately following the Effective Time, Genomic Health appointed Kevin T. Conroy as President, Jeffrey T. Elliott as Chief Financial Officer and G. Bradley Cole as General Manager, Precision Oncology. Kevin T. Conroy, age 54, has served as Exact Sciences' President and Chief Executive Officer since April 2009, as a director of Exact Sciences since March 2009 and as Chairman of the Exact Sciences' board of directors since March 2014.

Jeffrey T. Elliott, age 42, has served as Exact Sciences' Chief Financial Officer since November 2016. Prior to his appointment as Chief Financial Officer, Mr. Elliott served as Exact Sciences' Vice President, Business Development and Strategy, from June 2016 to November 2016. Prior to joining the Exact Sciences, from 2007 to 2016, Mr. Elliott was with Robert W. Baird & Co., where from June 2012 to June 2016 he was a senior research analyst who covered diagnostics and life science tools companies.

G. Bradley Cole, age 63, has served as Genomic Health's Chief Financial Officer since June 2014, and from July 2004 until January 2011. Mr. Cole also served as Genomic Health's Chief Operating Officer from January 2009 until March 2018.